Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
It mimics the GLP-1 hormone produced in your intestines to regulate blood sugar levels and appetite
They will use the products in compliance with all applicable laws and regulations
We have multiple communication channels to ensure a quality responsive service
Weve had clients message us two days after a shot to say the afternoon crash theyd lived with for months just lifted
US$ 26.50
US$ 21.44
US$ 20.82
US$ 25.57
US$ 27.02
